Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-30
1998-05-26
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514305, 514397, A61K 3144
Patent
active
057565147
ABSTRACT:
Methods of treating and preventing drug-induced pruritus in patients by administration of a serotonin type 3 antagonist are provided.
REFERENCES:
Crighton et al, Anaesthesia, 51(2), pp. 199-200, Feb. 1996.
Biosis AN 94:536734 Heim et al, Anaesthesist, 43(8), pp. 504-509, 1994.
Schworer et al, Clin. Investig, 71:659-662, 1993.
Naylor et al, Eur J Anaesthesiology, 9(Sup 6):3-10, 1992.
Gyermek, J Clin Pharmacol, 35:845-855, 1995.
Oxford et al, Progress in Medicinal Chem, vol. 29:239-270, 1992.
Schworer, H. and Ramadori, "Improvement of cholestatic pruritus by ondansetron", Lancet 1993 341:1277.
Schworer et al., "Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT.sub.3) receptor antagonists: effectiveness of ondansetron", Pain 1995 61(1):33-37.
LandOfFree
Methods for treatment and prevention of drug-induced pruritus wi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment and prevention of drug-induced pruritus wi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment and prevention of drug-induced pruritus wi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960433